Literature DB >> 21598069

Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas.

Dimitra Argyro Vassiliadi1, Georgia Ntali, Theodora Stratigou, Mersilena Adali, Stylianos Tsagarakis.   

Abstract

Aberrant receptors have been implicated in the pathogenesis of several types of adrenal tumours. So far the presence of aberrant receptors has been investigated in patients with massively enlarged adrenals due to ACTH-independent macronodular adrenal hyperplasia (AIMAH) and unilateral adrenal adenomas associated with overt or subclinical Cushing's syndrome. The likelihood of aberrant responses in patients presenting with bilateral adrenal incidentalomas (BI) presenting as discrete solitary bilateral adenomas has not been thoroughly addressed. This is an observational cross-sectional prospective study conducted in a secondary/tertiary care centre. We studied 33 patients; 28 with incidentally discovered bilateral discrete adrenal adenomas and five with massive bilateral adrenal macronodular hyperplasia. We probed responses to physiological stimuli, namely upright posture and meal; in a subgroup of menopausal women the presence of aberrant gonadotropin receptors was assessed by the LHRH test. Abnormal responses obtained in tests performed with no dexamethasone suppression were always repeated and confirmed under dexamethasone suppression. Aberrant cortisol responses were confirmed in 10 patients; 9 to posture, 1 to meal (along with a positive response to posture) and 1 to LHRH tests. Patients who responded to any test compared to those who tested negative had larger adenomas, higher post-LDDST and midnight cortisol and a trend for lower ACTH levels. Patients without subclinical hypercortisolism (SH) did not respond to any test while 50% of patients with SH had an aberrant response (P = 0.002). A greater prevalence of aberrant responses was noted in patients with bilateral macronodular hyperplasia compared to those with solitary bilateral adenomas (80 vs. 21.4%, P = 0.02). Aberrant cortisol responses, primarily to posture testing, are present in a substantial proportion of patients with bilateral adrenal incidentalomas. Such cortisol responses are observed only in patients with subclinical hypercortisolism and especially in those patients with larger adrenal lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598069     DOI: 10.1007/s12020-011-9490-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

1.  Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.

Authors:  Y Reznik; H Lefebvre; V Rohmer; B Charbonnel; A Tabarin; P Rodien; P Lecomte; S Bardet; C Coffin; J Mahoudeau
Journal:  Clin Endocrinol (Oxf)       Date:  2004-09       Impact factor: 3.478

Review 2.  Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction.

Authors:  André Lacroix; Isabelle Bourdeau; Antoine Lampron; Tânia L Mazzuco; Johanne Tremblay; Pavel Hamet
Journal:  Clin Endocrinol (Oxf)       Date:  2009-08-29       Impact factor: 3.478

3.  Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.

Authors:  S Tsagarakis; C Tsigos; V Vassiliou; P Tsiotra; H Pratsinis; D Kletsas; P Trivizas; A Nikou; T Mavromatis; F Sotsiou; S Raptis; N Thalassinos
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.

Authors:  L Barzon; C Scaroni; N Sonino; F Fallo; M Gregianin; C Macrì; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

5.  Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?

Authors:  H Mircescu; J Jilwan; N N'Diaye; I Bourdeau; J Tremblay; P Hamet; A Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.

Authors:  S Tsagarakis; C Roboti; P Kokkoris; V Vasiliou; C Alevizaki; N Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

7.  Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma.

Authors:  C Dall'Asta; E Ballarè; G Mantovani; B Ambrosi; A Spada; L Barbetta; P Colombo; P Travaglini; P Loli; P Beck-Peccoz
Journal:  Horm Metab Res       Date:  2004-08       Impact factor: 2.936

8.  Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone.

Authors:  Mark O Goodarzi; David W Dawson; Xian Li; Zhenmin Lei; Peter Shintaku; Chalama V Rao; Andre J Van Herle
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

9.  Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.

Authors:  Kenji Oki; Kiminori Yamane; Shuhei Nakanishi; Reiko Nakashima; Kuniaki Jitsuiki; Nobuoki Kohno
Journal:  Endocrine       Date:  2009-10-08       Impact factor: 3.633

10.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

View more
  6 in total

1.  Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Authors:  Zhanna E Belaya; Alexander V Iljin; Galina A Melnichenko; Liudmila Y Rozhinskaya; Natalia V Dragunova; Larisa K Dzeranova; Svetlana A Butrova; Ekaterina A Troshina; Ivan I Dedov
Journal:  Endocrine       Date:  2012-03-25       Impact factor: 3.633

Review 2.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

Review 3.  Glucose metabolism in patients with subclinical Cushing's syndrome.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Elisa Marinazzo; Andreea Picu; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-03-06       Impact factor: 3.633

4.  Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.

Authors:  Henrik Olsen; Erik Nordenström; Anders Bergenfelz; Ulf Nyman; Stig Valdemarsson; Erik Palmqvist
Journal:  Endocrine       Date:  2012-02-17       Impact factor: 3.633

5.  Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia.

Authors:  Sophie Comte-Perret; Anne Zanchi; Fulgencio Gomez
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-12-01

Review 6.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.